MELBOURNE, Australia--(BUSINESS WIRE)--Australian-based drug and development company Agenix Limited (ASX:AGX) today announced the appointment of Dr Paul Resnick as business advisor. Dr Resnick will initially focus on the Company’s revolutionary blood clot diagnostic ThromboView®.
